date:May 24, 2016
ake to reduce the risk of heart disease and obesity.
In 2014, FDA Deputy Commissioner Michael Taylor estimated the cost to industry at around $2 billion, although he said the regulations are projected to yield $20 billion to $30 billion in economic benefits. FDA estimated the sweeping proposal would impact roughly 60,000 manufacturers and more than 700,000 Universal Product Codes, representing approximately $236.78 billion in sales in grocery stores, drug stores and mass merchandise stores.
Th